Search Results 1741-1750 of 16884 for CLL

1. Implantable Cardioverter Defibrillator Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia - Mayo Clinic

   About this study. The purpose of this study is to compare the rate of arrhythmia-induced events between paediatric Catecholaminergic Polymorphic Ventricular ...

2. Publications - Melissa A. Lyle, M.D. - Mayo Clinic

   Sharma S, Ruiz J, Garg P, Leoni J, Patel P, Nativi J, Lyle M, Goswami R. Impella 5.5 in left ventricular noncompaction syndrome as bridge to heart transplant.

3. Pulmonary vein isolation - Doctors & Departments - Mayo Clinic

   This type of cardiac ablation uses heat or cold energy to treat atrial fibrillation. Learn how it's done and when you might need this treatment.

4. Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Research led by Mayo Clinic Establishes Mortality Risk for Refractory Celiac Disease Patients

   “Celiac disease is characterized by intestinal damage induced by the ingestion of gluten in susceptible individuals,” the study states. “Gluten-free diet is an ...

6. CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance - Mayo Clinic

   Also, to assess insulin sensitivity using the QUICKI measure and will assess changes after just 3 months in both ISS and QUICKI. Additionally, to assess whether ...

7. CT Clinical Innovation Center - History

   Learn how a CT physicist and a gastrointestinal radiologist worked together to found the CT Clinical Innovation Center at Mayo Clinic in 2004.

8. Publications - Julie A. Fields, Ph.D., L.P. - Mayo Clinic

   Armstrong MJ, Wollney E, Li Z, Dai Y, LaBarre B, Wang T, Sovich K, Jury HF, Galvin JE, Henriquez AM, Maixner SM, Paulson HL, Fields JA, Lunde A, Boeve BF, ...

9. A Study to Evaluate the Long-Term Effectives on ALS Disease Progression of BIIB067 - Mayo Clinic

   The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB067 in participants with amyotrophic lateral sclerosis (ALS) and ...

10. Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - Mayo Clinic

    About this study. RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.